Independent. Not affiliated with Eli Lilly or Novo Nordisk.Not medical advice. Your prescriber decides your treatment.
GLP-1 Field GuidePractical help, sourced from the label

GLP-1 eligibility checker

Do you qualify for Zepbound, Wegovy or Foundayo? Answer four quick questions to see whether you fit what the FDA labels cover, and the cheapest official way to pay with your insurance.

Compiled by the GLP-1 Field Guide editorUpdated 2 min readSourced from official labels. Not yet clinically reviewed.
Key points
  • The labels cover adults with a BMI of 30 or more, or 27 or more with a weight-related condition.
  • Your answers stay in your browser. Nothing is stored or sent.
  • Results show official prices from the makers and Medicare, checked weekly.
  • A licensed clinician makes the final decision.
  1. 1Age
  2. 2Height and weight
  3. 3Health
  4. 4Insurance
Are you 18 or older?

Your answers stay in your browser. We do not store or send them.

Prices in the results come from the makers' official pages and Medicare's fact sheet, and are re-checked every week on our price checker.[8, 9, 10, 11, 12, 7]

Who the labels cover

The FDA describes the weight-management population as adults with obesity (a BMI of 30 or more), or adults with overweight (a BMI of 27 or more) who have at least one weight-related condition, such as high blood pressure, type 2 diabetes or high cholesterol.[1] The Zepbound, Wegovy and Foundayo labels use the same wording.[2, 3, 4]

MedicineApproved for (adults)
ZepboundWeight management; moderate to severe obstructive sleep apnea with obesity
WegovyWeight management; reducing major cardiovascular events with established heart disease; injection also for a form of liver disease (MASH). Injection also for some patients aged 12 and older.
FoundayoWeight management (daily pill)
Mounjaro, OzempicType 2 diabetes (blood sugar), not weight management

From each prescribing information.[2, 3, 4, 5, 6]

Medicare GLP-1 Bridge rules

Medicare's fact sheet says you need all of these:[7]

  • Active Medicare Part D coverage, and no existing way to get a GLP-1 through your drug plan.
  • No type 2 diabetes, moderate to severe sleep apnea or fatty liver disease.
  • Age 18 or older and one of: a BMI of 35 or more; 30 or more with certain heart failure, hard-to-control high blood pressure or chronic kidney disease (stage 3a or above); or 27 or more with prediabetes or a history of heart attack, stroke or blocked arteries.

If you qualify, it costs $50 a month. Medicare must approve you before you pay. Full details are in ourZepbound savings guide.

When the labels say not to use them

Zepbound should not be used by anyone with a personal or family history of medullary thyroid cancer, or with Multiple Endocrine Neoplasia syndrome type 2 (MEN2).[1] The Wegovy label carries the same warning.[3] Your clinician will also ask about your other health conditions and medicines, which this checker does not cover.

Common questions

What BMI do you need for Zepbound or Wegovy?

The labels cover adults with obesity, which the FDA describes as a BMI of 30 or more, or adults with overweight (a BMI of 27 or more) who also have at least one weight-related condition such as high blood pressure, type 2 diabetes or high cholesterol. A clinician makes the final decision.

Can I get a GLP-1 with a BMI of 27?

Possibly. At a BMI of 27 to 29.9, the weight-management labels need at least one weight-related condition, such as high blood pressure, type 2 diabetes or high cholesterol. Without one, the labels do not cover that BMI range.

Does Medicare cover Wegovy or Zepbound for weight loss?

Through the Medicare GLP-1 Bridge, eligible people with Part D can get Zepbound (KwikPen), Wegovy or Foundayo for $50 a month. You need a BMI of 35 or more, or a lower BMI with certain conditions, and the Bridge excludes people with type 2 diabetes, moderate to severe sleep apnea or fatty liver disease.

Do I qualify if my insurance does not cover GLP-1s?

Coverage and eligibility are separate. If a clinician prescribes it, you can pay yourself: for example, Zepbound KwikPen or vials start at $299 a month for the 2.5 mg dose, and the Wegovy pill starts at $149 a month.

Is this checker medical advice?

No. It compares your answers with what the FDA labels and Medicare say. It does not diagnose anything or recommend a medicine or dose. A licensed clinician decides whether a medicine is right for you.

Not medical adviceThis guide explains what the official instructions say. Your prescriber and pharmacist know your situation, so ask them if anything here does not match what you were told.

Sources

  1. US Food and Drug Administration (press announcement). FDA approves new medication for chronic weight management. Revised November 8, 2023. Last checked 2026-10-13.
  2. Eli Lilly and Company. Zepbound (tirzepatide) Prescribing Information. Revised 08/2026. Last checked 2026-10-01.
  3. Novo Nordisk. Wegovy (semaglutide) Prescribing Information. Revised 06/2026. Last checked 2026-10-01.
  4. Eli Lilly and Company (via FDA). Foundayo (orforglipron) tablets Prescribing Information. Revised 07/2026. Last checked 2026-10-01.
  5. Eli Lilly and Company. Mounjaro (tirzepatide) Prescribing Information. Revised 08/2026. Last checked 2026-10-01.
  6. Novo Nordisk. Ozempic (semaglutide) Prescribing Information, Medication Guide and Instructions for Use. Revised PI 05/2026, Medication Guide 01/2025 (IFU date unconfirmed). Last checked 2026-10-01.
  7. Centers for Medicare and Medicaid Services. Medicare GLP-1 Bridge: GLP-1 Drugs for $50 a Month (fact sheet). Revised n/a (program began July 1, 2026). Last checked 2026-10-01.
  8. Eli Lilly and Company. Zepbound savings and coverage options. Revised n/a (web page, programs through 12/31/2026). Last checked 2026-11-04.
  9. Novo Nordisk. Wegovy savings, self pay and home delivery (NovoCare Pharmacy). Revised n/a (web page). Last checked 2026-11-04.
  10. Novo Nordisk. Savings Offer program for Wegovy. Revised n/a (web page). Last checked 2026-10-01.
  11. Eli Lilly and Company. Foundayo on LillyDirect. Revised n/a (web page; some prices reduced through 12/31/2026). Last checked 2026-11-04.
  12. Eli Lilly and Company. Foundayo coverage and savings. Revised n/a (web page; savings card through 12/31/2026). Last checked 2026-11-04.
GLP-1 price checkerEvery brand and dose, checked weekly.Getting a prescription onlineHow licensed telehealth works.Zepbound savings guideSavings card and Medicare rules.Wegovy and Ozempic savingsNovoCare offers and savings cards.